<PAGE>
<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
--------------------
SCHEDULE 13G
Information Pursuant to Rules 13d-1 and 13d-2
Under the Securities Act of 1934
(Amendment No. 1)
Halsey Drug Co., Inc.
----------------------------------------
(Name of Issuer)
Common Stock
----------------------------------------
(Title of Class of Securities)
406369
----------------------------------------
(CUSIP Number)
----------------------------------------
The information required in the remainder of this cover page (except any items
to which the form provides a cross-reference) shall not be deemed to be "filed"
for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or
otherwise subject to the liabilities of that section of the Act but shall be
subject to all other provisions of the Act.
<PAGE>
<PAGE>
- --------------------------- ---------------------
CUSIP No. 406369 13G Page 2 of 11 Pages
- --------------------------- ---------------------
<TABLE>
<C> <S> <C>
- ----------------------------------------------------------------------------------------------
1 Name of Reporting Person The Chase Manhattan Corporation
I.R.S. Identification No. of Above Person
- ----------------------------------------------------------------------------------------------
2 Check the Appropriate Box if a Member of a Group (See Instructions) (a) [ ]
(b) [X]
- ----------------------------------------------------------------------------------------------
3 SEC Use Only
- ----------------------------------------------------------------------------------------------
4 Citizenship or Place of Organization
Delaware
- ----------------------------------------------------------------------------------------------
Number of 5 Sole Voting Power
Shares
----------------------------------------------------------------------------
Beneficially 6 Shared Voting Power
Owned by
----------------------------------------------------------------------------
Each 7 Sole Dispositive Power
Reporting
----------------------------------------------------------------------------
Person With 8 Shared Dispositive Power
- ----------------------------------------------------------------------------------------------
9 Aggregate Amount Beneficially Owned by Each Reporting Person
- ----------------------------------------------------------------------------------------------
10 Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
[ ]
- ----------------------------------------------------------------------------------------------
11 Percent of Class Represented by Amount in Row (9)
- ----------------------------------------------------------------------------------------------
12 Type of Reporting Person (See Instructions)
HC
- ----------------------------------------------------------------------------------------------
</TABLE>
<PAGE>
<PAGE>
- --------------------------- ---------------------
CUSIP No. 406369 13G Page 3 of 11 Pages
- --------------------------- ---------------------
<TABLE>
<C> <S> <C>
- ----------------------------------------------------------------------------------------------
1 Name of Reporting Person The Bank of New York
I.R.S. Identification No. of Above Person
- ----------------------------------------------------------------------------------------------
2 Check the Appropriate Box if a Member of a Group (See Instructions) (a) [ ]
(b) [X]
- ----------------------------------------------------------------------------------------------
3 SEC Use Only
- ----------------------------------------------------------------------------------------------
4 Citizenship or Place of Organization
New York
- ----------------------------------------------------------------------------------------------
Number of 5 Sole Voting Power
Shares
----------------------------------------------------------------------------
Beneficially 6 Shared Voting Power
Owned by
----------------------------------------------------------------------------
Each 7 Sole Dispositive Power
Reporting
----------------------------------------------------------------------------
Person With 8 Shared Dispositive Power
- ----------------------------------------------------------------------------------------------
9 Aggregate Amount Beneficially Owned by Each Reporting Person
- ----------------------------------------------------------------------------------------------
10 Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
[ ]
- ----------------------------------------------------------------------------------------------
11 Percent of Class Represented by Amount in Row (9)
- ----------------------------------------------------------------------------------------------
12 Type of Reporting Person (See Instructions)
BK
- ----------------------------------------------------------------------------------------------
</TABLE>
<PAGE>
<PAGE>
- --------------------------- ---------------------
CUSIP No. 406369 13G Page 4 of 11 Pages
- --------------------------- ---------------------
<TABLE>
<C> <S> <C>
- ----------------------------------------------------------------------------------------------
1 Name of Reporting Person Israel Discount Bank of New York
I.R.S. Identification No. of Above Person
- ----------------------------------------------------------------------------------------------
2 Check the Appropriate Box if a Member of a Group (See Instructions) (a) [ ]
(b) [X]
- ----------------------------------------------------------------------------------------------
3 SEC Use Only
- ----------------------------------------------------------------------------------------------
4 Citizenship or Place of Organization
New York
- ----------------------------------------------------------------------------------------------
Number of 5 Sole Voting Power
Shares
----------------------------------------------------------------------------
Beneficially 6 Shared Voting Power
Owned by
----------------------------------------------------------------------------
Each 7 Sole Dispositive Power
Reporting
----------------------------------------------------------------------------
Person With 8 Shared Dispositive Power
- ----------------------------------------------------------------------------------------------
9 Aggregate Amount Beneficially Owned by Each Reporting Person
- ----------------------------------------------------------------------------------------------
10 Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
[ ]
- ----------------------------------------------------------------------------------------------
11 Percent of Class Represented by Amount in Row (9)
- ----------------------------------------------------------------------------------------------
12 Type of Reporting Person (See Instructions)
BK
- ----------------------------------------------------------------------------------------------
</TABLE>
<PAGE>
<PAGE>
- --------------------------- ---------------------
CUSIP No. 406369 13G Page 5 of 11 Pages
- --------------------------- ---------------------
This Amendment No. 1 amends and supplements the Statement on Schedule 13G (the
"Schedule 13G"), originally filed in 1995 with the Securities and Exchange
Commission. Items 1-10 of the Schedule 13G are hereby amended in their entirety
to read as follows:
Item 1(a) Name of Issuer:
Halsey Drug Co., Inc.
Item 1(b) Address of Issuer's Principal Executive Offices:
1827 Pacific Street, Brooklyn, New York 11233
Item 2(a) Name of Person(s) Filing:
The Chase Manhattan Corporation
Name of Person(s) Filing:
The Chase Manhattan Bank
as successor in interest to The Chase Manhattan Bank, N.A.
Name of Person(s) Filing:
The Bank of New York
Name of Person(s) Filing:
Israel Discount Bank of New York
Item 2(b) Address of Principal Business Office:
270 Park Avenue, New York, New York 10017
Address of Principal Business Office:
270 Park Avenue, New York, New York 10017
Address of Principal Business Office:
One Wall Street, New York, New York 10286
<PAGE>
<PAGE>
- --------------------------- ---------------------
CUSIP No. 406369 13G Page 6 of 11 Pages
- --------------------------- ---------------------
Address of Principal Business Office:
511 Fifth Avenue, New York, New York 10017
Item 2(c) Citizenship:
Delaware (The Chase Manhattan Corporation)
Citizenship:
New York (The Chase Manhattan Bank)
Citizenship:
New York (The Bank of New York)
Citizenship:
New York (Israel Discount Bank of New York)
Item 2(d) Title of Class of Securities:
Common Stock of Halsey Drug Co., Inc. (warrants to purchase)
Item 2(e) CUSIP Number:
406369
Item 3 If this statement is filed pursuant to Rules 13d-1(b), or
13d-2(b), check whether the person filing is a:
(a) [ ] Broker or dealer registered under Section 15 of the
Act,
(b) [X] Bank as defined in Section 3(a)(6) of the Act,
(c) [ ] Insurance Company as defined in Section 3(a)(19) of the
Act,
(d) [ ] Investment Company registered under Section 8 of the
Investment Company Act,
(e) [ ] Investment Advisor registered under Section 203 of the
Investment Advisors Act of 1940,
<PAGE>
<PAGE>
- --------------------------- ---------------------
CUSIP No. 406369 13G Page 7 of 11 Pages
- --------------------------- ---------------------
(f) [ ] Employee Benefit Plan, Pension Fund which is subject to
the provisions of the Employee Retirement Income
Security Act of 1974 or Endowment Fund; see
13d-1(b)(1)(ii)(F),
(g) [X] Parent Holding Company, in accordance with Rule
13d-1(b)(ii)(G); see Item 7,
(h) [ ] Group, in accordance with Rule 13d-1(b)(1)(ii)(H).
Item 4 Ownership.
[Not applicable.]
Item 5. Ownership of Five Percent or Less of a Class.
If this statement is being filed to report the fact that as of
the date hereof, the reporting persons have ceased (collectively)
to be the beneficial owner of more than five percent of the class
of securities, check the following [X].
Item 6. Ownership of More than 5% on Behalf of Another Person.
[Not Applicable]
Item 7. Identification and Classification of the Subsidiary Which
Acquired the Security Being Reported on By the Parent Holding
Company.
As to the Chase Manhattan Corporation, this schedule is filed
pursuant to Rule 13d-1(b)(ii)(G). The Chase Manhattan Bank is a
wholly-owned subsidiary of The Chase Manhattan Corporation and is
a bank as defined in Section 3(a)(6) of the Act.
Item 8. Identification and Classification of Members of the Group.
The Chase Manhattan Corporation ("CMC") is a parent holding
company and each of The Chase Manhattan Bank, as successor in
interest to The Chase Manhattan Bank, N.A. ("Chase"), The Bank of
New York ("BNY") and Israel Discount Bank of New York ("IDB") is
a bank as defined in Section 3(a)(6) of the Act. CMC, Chase, BNY
and IDB expressly disclaim that they constitute a "group" for
purposes of Section 13(d) of the Act and the Rules and
Regulations promulgated thereunder. Chase, BNY and IDB are
parties to a Credit Agreement, dated as of December 22, 1992,
among Halsey Drug Co., Inc. (the
<PAGE>
<PAGE>
- --------------------------- ---------------------
CUSIP No. 406369 13G Page 8 of 11 Pages
- --------------------------- ---------------------
"Issuer"), Chase, BNY and IDB (such agreement, as amended from
time to time, the "Credit Agreement"). In connection with various
amendments to the Credit Agreement, Chase, BNY and IDB have
received warrants to purchase common stock of the Issuer. Such
warrants, which were received in 1994 or early 1995 (but were all
dated 1994), are the basis for this filing.
Item 9. Notice of Dissolution of the Group.
[Not Applicable]
Item 10. Certification.
By signing below each of the undersigned certifies that, to the
best of such person's knowledge and belief, the securities
referred to above were acquired in the ordinary course of
business and were not acquired for the purpose of and do not have
the effect of changing or influencing the control of the issuer
of such securities and were not acquired in connection with or as
a participant in any transaction having such purpose or effect.
<PAGE>
<PAGE>
- --------------------------- ---------------------
CUSIP No. 406369 13G Page 9 of 11 Pages
- --------------------------- ---------------------
SIGNATURE
After reasonable inquiry and to the best of their knowledge and belief,
each of the undersigned certify that the information set forth in this statement
is true, complete and correct.
Date: February 17, 1998 THE CHASE MANHATTAN CORPORATION
By: /s/ ANTHONY J. HORAN
_________________________________
Name: Anthony J. Horan
Title: Corporate Secretary
Date: February 17, 1998 THE CHASE MANHATTAN BANK
By: /s/ DOUGLAS A. JENKS
_________________________________
Name: Douglas A. Jenks
Title: Vice President
Dated: February 17, 1998 THE BANK OF NEW YORK
By: /s/ J.B. LIFTON
_________________________________
Name: J.B. Lifton
Title: Vice President
Dated: February 17, 1998 ISRAEL DISCOUNT BANK OF NEW YORK
By: /s/ HOWARD WEINBERG
_________________________________
Name: Howard Weinberg
Title: First Vice President
By: /s/ R. DAVID KORNGRUEN
_________________________________
Name: R. David Korngruen
Title: Vice President
<PAGE>
<PAGE>
Exhibit Index
Exhibit I Joint Filing Agreement, dated as of October 23, 1995, by and
among The Chase Manhattan Bank, The Bank of New York and
Israel Discount Bank.
<PAGE>
<PAGE>
JOINT FILING AGREEMENT
In accordance with Rule 13d-1(f) of the Securities Exchange Act
of 1934, as amended, (the "Act") the persons named below agree to the joint
filing on behalf of each of them of a statement on Schedule 13G (including
amendments thereto) with respect to common stock of Halsey Drug Co., Inc.
(including warrants to acquire the same) and further agree that this Joint
Filing Agreement be included as an exhibit to such joint filings.
Notwithstanding this Joint Filing Agreement, the persons named below disclaim
that they constitute a "group" for purposes of Section 13d of the Act and the
rules and regulations promulgated in connection therewith. In evidence thereof,
the undersigned have executed this Joint Filing Agreement as of the 23rd day of
October 1997.
THE CHASE MANHATTAN CORPORATION
10/24/95
_________________________________________
(Date)
JOHN V. CAULFIELD
_________________________________________
(Signature)
John V. Caulfield V.P.
_________________________________________
(Name/Title)
THE CHASE MANHATTAN BANK
10/24/95
_________________________________________
(Date)
JOHN V. CAULFIELD
_________________________________________
(Signature)
John V. Caulfield V.P.
_________________________________________
<PAGE>
<PAGE>
(Name/Title)
THE BANK OF NEW YORK
10/23/95
_________________________________________
(Date)
RICHARD MAYBAUM
_________________________________________
(Signature)
Richard Maybaum A.V.P.
_________________________________________
(Name/Title)
ISRAEL DISCOUNT BANK OF NEW YORK
October 23, 1995
_________________________________________
(Date)
GEORGE S. DALLAL
_________________________________________
(Signature)
George S. Dallal, V.P.
_________________________________________
(Name/Title)
October 23,1995
_________________________________________
(Date)
R. DAVID KORNGRUEN
_________________________________________
(Signature)
R. David Korngruen A.V.P.
_________________________________________
(Name/Title)
